TABLE.
Author (date of publication) | Purpose | Inclusion criteria | Outcome variables | Level of evidence |
---|---|---|---|---|
Canto et al8 (1997) | To compare characteristics and outcomes of patients with or without PH ECG | Hospitalized patients with AMI who presented by ambulance to emergency department | Time to first ECG, time to reperfusion therapy, clinical outcomes (reinfarction, heart failure, hypotension, death) | IIb |
Ioannidis et al9 (2001) | To assess diagnostic performance of PH ECG | Studies about patients with chest pain who received PH ECG; both RCT and non-RCT studies included for meta-analysis | Sensitivity, specificity, clinical outcomes (death) | Ia |
Brainard et al6 (2005) | To compare time to reperfusion in patients with or without PH ECG | Studies that reported time savings of PH ECG; all needed to report original data | Onset of symptoms—to—reperfusion time | Ia |
Curtis et al7 (2006) | To evaluate prevalence of PH ECG and effects of PH ECG on reperfusion times | Patients with STEMI or new left bundle branch block who received acute reperfusion therapy | Door-to-drug time and door-to-balloon time | IIb |
Eckstein et al10 (2009) | To compare time to reperfusion in patients with or without PH ECG | Patients with admission diagnosis of STEMI | Door-to-balloon time | IIb |
Diercks et al12 (2009) | To compare time to reperfusion and clinical outcomes in patients with or without PH ECG | Patients with admission diagnosis of STEMI | Door-to-balloon time, clinical outcomes (death, heart failure, cardiogenic shock) | IIb |
Drew et al13 (2011) | To compare time to reperfusion and clinical outcomes (scene time) in patients with or without PH ECG | Patients activating EMS with chest pain and/or anginal equivalent | Scene time, time to first ECG, time to reperfusion, clinical outcomes (death) | Ib |
AMI, Acute myocardial I’nfarction; RCT, randomized control trial.